Latest Breaking News On - Eibomian gland disease - Page 1 : comparemela.com

Tarsus Pharmaceuticals, Inc. (TARS) announced Monday positive topline results from the Ersa Phase 2a clinical trial evaluating TP-03 (lotilaner ophthalmic solution, 0.

Bobak azamianTarsus pharmaceuticals incDrug administrationMore such health newsTarsus pharmaceuticalsErsa phaseMeibomian gland diseaseMeibomian gland secretion scoreChief executive officerEp 03Eibomian gland diseaseDemodex mites